Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 20.848.257,47, with a 24-hour trading volume of Rp 15,36B. The asset's market cap is Rp 18,59P, after moving -0.06% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 20.957.275,2, with a tokenized market cap of Rp 816,77B and a 24-hour trading volume of Rp 34,15B. The tokenized asset has moved -0.18% in the past 24 hours.